Immune checkpoint blockade PD-1 therapy for primary liver cancer: incidence and influencing factors of thyroid dysfunction

To investigate the incidence and influencing factors of thyroid dysfunction (TD) in patients with primary liver cancer (PLC) induced by PD-1 monoclonal antibodies.

Source: Infectious Agents and Cancer - December 29, 2022 Category: Cancer & Oncology Authors: Huili Wu, Fang Xiong, Xuli Bao and Jun Lu Tags: Research Source Type: research